marbofloxacin has been researched along with Infections, Pasteurella in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorey, L; Lees, P | 1 |
| Ding, H; Li, Z; Liang, C; Lv, Z; Shan, Q; Wang, J; Yang, F; Zeng, Z | 1 |
| Cao, C; Liang, C; Lu, Y; Qiu, Z; Qu, Y; Sun, M; Zeng, Z | 1 |
| Dorey, L; Hobson, S; Lees, P | 1 |
| Abo-el-Sooud, K; Goudah, A | 1 |
| Bousquet-Mélou, A; Ferran, AA; Toutain, PL | 1 |
| Cheng, Z; Fishwick, J; Illambas, J; Lees, P; Potter, T; Rycroft, A | 1 |
2 trial(s) available for marbofloxacin and Infections, Pasteurella
| Article | Year |
|---|---|
Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Body Fluids; Cattle; Cattle Diseases; Cross-Over Studies; Exudates and Transudates; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida | 2014 |
Influence of Pasteurella multocida infection on the pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in rabbits.
Topics: Animals; Area Under Curve; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Male; Pasteurella Infections; Pasteurella multocida; Rabbits | 2010 |
5 other study(ies) available for marbofloxacin and Infections, Pasteurella
| Article | Year |
|---|---|
Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Microbial Sensitivity Tests; Oxytetracycline; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Swine; Swine Diseases; Thiamphenicol | 2017 |
Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Neutropenia; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Specific Pathogen-Free Organisms | 2015 |
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia; Swine; Swine Diseases | 2017 |
Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Fluoroquinolones; Lung; Mice; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2011 |
Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Dose-Response Relationship, Drug; Fluoroquinolones; In Vitro Techniques; Mannheimia haemolytica; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia of Calves, Enzootic | 2013 |